Zobrazeno 1 - 10
of 324
pro vyhledávání: '"Paolo, Anderlini"'
Autor:
Harjeet Singh, Samer A. Srour, Denái R. Milton, Jessica McCarty, Cuiping Dai, Mahmoud R. Gaballa, Mariam Ammari, Simon Olivares, Helen Huls, Eleanor De Groot, David Marin, Demetrios Petropoulos, Amanda L. Olson, Paolo Anderlini, Jin S. Im, Issa Khouri, Chitra M. Hosing, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Laurence J. N. Cooper, Partow Kebriaei
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Chimeric antigen receptor (CAR) T-cell therapy has emerged recently as a standard of care treatment for patients with relapsed or refractory acute lymphoblastic leukemia (ALL) and several subtypes of B-cell non-Hodgkin lymphoma (NHL). However, its us
Externí odkaz:
https://doaj.org/article/9569f80e06114c10ac15c8046aef34f8
Autor:
Yago Nieto, Stephen Gruschkus, Benigno C. Valdez, Roy B. Jones, Paolo Anderlini, Chitra Hosing, Uday Popat, Muzaffar Qazilbash, Partow Kebriaei, Amin Alousi, Neeraj Saini, Samer Srour, Katayoun Rezvani, Jeremy Ramdial, Melissa Barnett, Alison Gulbis, Terri Lynn Shigle, Sairah Ahmed, Swaminathan Iyer, Hun Lee, Ranjit Nair, Simrit Parmar, Raphael Steiner, Bouthaina Dabaja, Chelsea Pinnix, Jillian Gunther, Branko Cuglievan, Kris Mahadeo, Sajad Khazal, Hubert Chuang, Richard Champlin, Elizabeth J. Shpall, Borje S. Andersson
Publikováno v:
Haematologica, Vol 107, Iss 4 (2021)
High-dose chemotherapy and autologous stem-cell transplant (HDC/ASCT) is standard treatment for chemosensitive relapsed classical Hodgkin lymphoma, although outcomes of high-risk relapse (HRR) patients remain suboptimal. We retrospectively analyzed a
Externí odkaz:
https://doaj.org/article/20d140bbdb7c4c2e996502cd045e920c
Autor:
Rohtesh S. Mehta, Roland Bassett, Amanda Olson, Julianne Chen, Sairah Ahmed, Amin M. Alousi, Paolo Anderlini, Gheath Al-Atrash, Qaiser Bashir, Stefan O. Ciurea, Chitra M. Hosing, Jin S. Im, Partow Kebriaei, Issa Khouri, David Marin, Jeffrey J. Molldrem, Yago Nieto, Betul Oran, Katayoun Rezvani, Muzaffar H. Qazilbash, Samer A. Srour, Elizabeth J. Shpall, Borje S. Andersson, Richard E. Champlin, Uday R. Popat
Publikováno v:
Haematologica, Vol 104, Iss 12 (2019)
Externí odkaz:
https://doaj.org/article/076bc57ebf834908ada91351e2aa8d1f
Autor:
Michael A. Pulsipher, Brent R. Logan, Deidre M. Kiefer, Pintip Chitphakdithai, Marcie L. Riches, J. Douglas Rizzo, Paolo Anderlini, O’Susan F. Leitman, Hati Kobusingye, RaeAnne M. Besser, John P. Miller, Rebecca J. Drexler, Aly Abdel-Mageed, Ibrahim A. Ahmed, Luke P. Akard, Andrew S. Artz, Edward D. Ball, Ruthee-Lu Bayer, Carolyn Bigelow, Brian J. Bolwell, E. Randolph Broun, David C. Delgado, Katharine Duckworth, Christopher C. Dvorak, Theresa E. Hahn, Ann E. Haight, Parameswaran N. Hari, Brandon M. Hayes-Lattin, David A. Jacobsohn, Ann A. Jakubowski, Kimberly A. Kasow, Hillard M. Lazarus, Jane L. Liesveld, Michael Linenberger, Mark R. Litzow, Walter Longo, Margarida Magalhaes-Silverman, John M. McCarty, Joseph P. McGuirk, Shahram Mori, Vinod Parameswaran, Vinod K. Prasad, Scott D. Rowley, Witold B. Rybka, Indira Sahdev, Jeffrey R. Schriber, George B. Selby, Paul J. Shaughnessy, Shalini Shenoy, Thomas Spitzer, William T. Tse, Joseph P. Uberti, Madhuri Vusirikala, Edmund K. Waller, Daniel J. Weisdorf, Gregory A. Yanik, Willis H. Navarro, Mary M. Horowitz, Galen E. Switzer, Dennis L. Confer, Bronwen E. Shaw
Publikováno v:
Haematologica, Vol 104, Iss 4 (2019)
Unlike unrelated donor registries, transplant centers lack uniform approaches to related donor assessment and deferral. To test whether related donors are at increased risk for donation-related toxicities, we conducted a prospective observational tri
Externí odkaz:
https://doaj.org/article/fdcd298454b34e89b6d33b8ea6f81372
Autor:
Issa F. Khouri, Ken H. Young, Homer A. Macapinlac, L. Jeffrey Medeiros, Elias J. Jabbour, Roland L. Bassett, Luis E. Fayad, Betul Oran, Stefan O. Ciurea, Paolo Anderlini, Gheath Alatrash, Sairah Ahmed, Mingzhi Zhang, Martin Korbling, Alison M. Gulbis, William D. Erwin, Dawen Sui, Jad Chahoud
Progression-free survival curves for groups A, B, C, and D.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b25cff2a278558dec382ba76692db1f8
https://doi.org/10.1158/1078-0432.22469714
https://doi.org/10.1158/1078-0432.22469714
Autor:
Issa F. Khouri, Ken H. Young, Homer A. Macapinlac, L. Jeffrey Medeiros, Elias J. Jabbour, Roland L. Bassett, Luis E. Fayad, Betul Oran, Stefan O. Ciurea, Paolo Anderlini, Gheath Alatrash, Sairah Ahmed, Mingzhi Zhang, Martin Korbling, Alison M. Gulbis, William D. Erwin, Dawen Sui, Jad Chahoud
Purpose: We evaluated the effect on long-term survival of adding rituximab (R) to BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning with or without yttrium-90 ibritumomab tiuxetan (90YIT) in patients with relapsed diffuse large B-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ac76d323f32b8c3a1080e1daa7a307d
https://doi.org/10.1158/1078-0432.c.6527318
https://doi.org/10.1158/1078-0432.c.6527318
Autor:
Issa F. Khouri, Ken H. Young, Homer A. Macapinlac, L. Jeffrey Medeiros, Elias J. Jabbour, Roland L. Bassett, Luis E. Fayad, Betul Oran, Stefan O. Ciurea, Paolo Anderlini, Gheath Alatrash, Sairah Ahmed, Mingzhi Zhang, Martin Korbling, Alison M. Gulbis, William D. Erwin, Dawen Sui, Jad Chahoud
Patient demographic characteristics and baseline disease characteristics for groups A, B, C, and D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a8b2997853e2ad21e246c9c18979a49
https://doi.org/10.1158/1078-0432.22469711
https://doi.org/10.1158/1078-0432.22469711
Autor:
David Marin, Elias Jabbour, Denái R. Milton, Amanda Olson, Gabriela Rondon, Jin S. Im, Rohtesh S. Mehta, Uday R. Popat, May Daher, Felipe Samaniego, Loretta J. Nastoupil, Neeraj Saini, Celina Ledesma, Paolo Anderlini, Muzaffar H. Qazilbash, Qaiser Bashir, Issa F. Khouri, Alison M. Gulbis, Richard E. Champlin, L. Jeffrey Medeiros, Swaminathan P. Iyer
Publikováno v:
Clinical Cancer Research. 27:5847-5856
Purpose: To compare outcomes between patients with relapsed follicular lymphoma who received a nonmyeloablative allogeneic stem cell transplant (alloSCT) and those who received an autologous transplant (autoSCT). Patients and Methods: We evaluated 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a09fabc0786a92474a5a7a85eeae3805
https://doi.org/10.1158/1078-0432.ccr-21-1377
https://doi.org/10.1158/1078-0432.ccr-21-1377
Autor:
Natasha Kekre, Ying Zhang, Mei-Jie Zhang, Jeanette Carreras, Parvez Ahmed, Paolo Anderlini, Elias Hallack Atta, Mouhab Ayas, Jaap Jan Boelens, Carmem Bonfim, H. Joachim Deeg, Neena Kapoor, Jong-Wook Lee, Ryotaro Nakamura, Michael A. Pulsipher, Mary Eapen, Joseph H. Antin
Publikováno v:
Haematologica, Vol 102, Iss 7 (2017)
For treatment of severe aplastic anemia, immunosuppressive therapy with horse antithymocyte globulin results in superior response and survival compared with rabbit antithymocyte globulin. This relative benefit may be different in the setting of trans
Externí odkaz:
https://doaj.org/article/b00ea5f1d30e445083f65f4b050b39a6
Autor:
Jillian R. Gunther, Bouthaina S. Dabaja, Swaminathan Padmanabhan Iyer, Richard E. Champlin, Melissa Barnett, Hubert H. Chuang, Sajad Khazal, Borje S. Andersson, Benigno C. Valdez, Neeraj Saini, Terri Lynn Shigle, Branko Cuglievan, Ranjit Nair, Chitra Hosing, Amin M. Alousi, Hun Lee, Kris Michael Mahadeo, Paolo Anderlini, Samer A. Srour, Sairah Ahmed, Simrit Parmar, Yago Nieto, Elizabeth J. Shpall, Raphael E Steiner, Muzaffar H. Qazilbash, Chelsea C. Pinnix, Uday R. Popat, Alison M. Gulbis, Partow Kebriaei, Katayoun Rezvani, Roy B. Jones, Stephen K. Gruschkus, Jeremy Ramdial
Publikováno v:
Haematologica. 107:899-908
High-dose chemotherapy and autologous stem-cell transplant (HDC/ASCT) is standard treatment for chemosensitive relapsed classical Hodgkin lymphoma, although outcomes of high-risk relapse (HRR) patients remain suboptimal. We retrospectively analyzed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23e6d7f167da9375fb35bc23947e9195
https://doi.org/10.3324/haematol.2021.278311
https://doi.org/10.3324/haematol.2021.278311